A Study to Evaluate the Efficacy of Everolimus in Patients With Autoimmune Hepatitis (AIH) who Exhibits Nonresponse or Intolerance To Combinations of the Standard and Empirical Drugs In Use

Trial Profile

A Study to Evaluate the Efficacy of Everolimus in Patients With Autoimmune Hepatitis (AIH) who Exhibits Nonresponse or Intolerance To Combinations of the Standard and Empirical Drugs In Use

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Autoimmune hepatitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top